2019
DOI: 10.1038/s41598-019-47712-5
|View full text |Cite
|
Sign up to set email alerts
|

Do population-level risk prediction models that use routinely collected health data reliably predict individual risks?

Abstract: The objective of this study was to assess the reliability of individual risk predictions based on routinely collected data considering the heterogeneity between clinical sites in data and populations. Cardiovascular disease (CVD) risk prediction with QRISK3 was used as exemplar. The study included 3.6 million patients in 392 sites from the Clinical Practice Research Datalink. Cox models with QRISK3 predictors and a frailty (random effect) term for each site were used to incorporate unmeasured site variability.… Show more

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
2
1
1
1

Citation Types

0
37
0
1

Year Published

2020
2020
2024
2024

Publication Types

Select...
6
1

Relationship

3
4

Authors

Journals

citations
Cited by 24 publications
(38 citation statements)
references
References 27 publications
0
37
0
1
Order By: Relevance
“…We used the Markov chain Monte Carlo method with monotone style to impute missing values 10 times for ethnicity ( 18 (only these variables had missing values). We randomly split the overall cohort (which contained 10 imputations) into an overall derivation cohort (75%) and an overall testing cohort (25%).…”
Section: Discussionmentioning
confidence: 99%
See 1 more Smart Citation
“…We used the Markov chain Monte Carlo method with monotone style to impute missing values 10 times for ethnicity ( 18 (only these variables had missing values). We randomly split the overall cohort (which contained 10 imputations) into an overall derivation cohort (75%) and an overall testing cohort (25%).…”
Section: Discussionmentioning
confidence: 99%
“…24 This was different from QRISK3, for which a single calendar time date was mostly used. 18 The main inclusion criteria were age between 25 and 84 years, no history of cardiovascular disease, and no prescription for a statin before the index date. The outcome of interest was the 10 year risk of developing cardiovascular disease.…”
Section: Data Sourcementioning
confidence: 99%
“…biomarkers) or practice level, which could reduce the unmeasured heterogeneity in CVD incidence across practices. Further research could consider more individual level based methods, such as a Bayesian clinical reasoning model 33 and machine learning models 34 , as this study and other findings 18,35,36 show that Cox models with similar conventional model performance metrics (C-stat 37…”
Section: Implications For Research and Practicementioning
confidence: 54%
“…QRISK3 is the most popular risk prediction model for CVD developed in the UK. It calculates risk of patients developing CVD in the next 10 years and has been incorporated into the electronic health records (EHRs) system in the UK in order to detect high risk CVD patients and help clinicians make treatment decisions 3,4 . NICE guidelines recommend clinicians to consider prescribing statins to patients with a risk over 10% identified from QRISK3 5 .…”
Section: Introductionmentioning
confidence: 99%
“…NICE guidelines recommend clinicians to consider prescribing statins to patients with a risk over 10% identified from QRISK3 5 . QRISK3 was developed from historical patients' EHR data using Cox proportional hazard model 6 and has been well validated at population level corresponding to discrimination and calibration 3,4,7 .…”
Section: Introductionmentioning
confidence: 99%